Blair William & Co. IL Sells 395 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Blair William & Co. IL trimmed its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 3.3% in the 3rd quarter, Holdings Channel reports. The fund owned 11,697 shares of the medical instruments supplier’s stock after selling 395 shares during the quarter. Blair William & Co. IL’s holdings in DENTSPLY SIRONA were worth $512,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently made changes to their positions in XRAY. First Trust Advisors LP increased its position in DENTSPLY SIRONA by 203.9% during the first quarter. First Trust Advisors LP now owns 91,083 shares of the medical instruments supplier’s stock worth $4,517,000 after acquiring an additional 61,111 shares during the period. Amundi Pioneer Asset Management Inc. increased its holdings in shares of DENTSPLY SIRONA by 39.9% during the 1st quarter. Amundi Pioneer Asset Management Inc. now owns 184,628 shares of the medical instruments supplier’s stock worth $9,157,000 after purchasing an additional 52,645 shares during the period. Assenagon Asset Management S.A. raised its position in shares of DENTSPLY SIRONA by 17.6% during the second quarter. Assenagon Asset Management S.A. now owns 39,241 shares of the medical instruments supplier’s stock valued at $1,729,000 after buying an additional 5,871 shares during the last quarter. Janney Montgomery Scott LLC grew its position in DENTSPLY SIRONA by 151.0% during the second quarter. Janney Montgomery Scott LLC now owns 131,488 shares of the medical instruments supplier’s stock worth $5,793,000 after buying an additional 79,098 shares in the last quarter. Finally, Hardman Johnston Global Advisors LLC lifted its position in shares of DENTSPLY SIRONA by 0.9% in the 2nd quarter. Hardman Johnston Global Advisors LLC now owns 515,840 shares of the medical instruments supplier’s stock worth $22,728,000 after acquiring an additional 4,610 shares during the period. Institutional investors and hedge funds own 96.00% of the company’s stock.

Shares of XRAY opened at $49.40 on Friday. The stock’s fifty day simple moving average is $46.97 and its 200-day simple moving average is $44.69. The firm has a market capitalization of $10.80 billion, a PE ratio of -214.78, a price-to-earnings-growth ratio of 5.06 and a beta of 0.98. DENTSPLY SIRONA Inc. has a 12-month low of $31.58 and a 12-month high of $60.87. The company has a quick ratio of 2.38, a current ratio of 3.10 and a debt-to-equity ratio of 0.47.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, November 5th. The medical instruments supplier reported $0.67 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.32 by $0.35. DENTSPLY SIRONA had a negative net margin of 1.40% and a positive return on equity of 7.13%. The company had revenue of $895.00 million for the quarter, compared to the consensus estimate of $839.02 million. During the same period in the prior year, the company posted $0.57 EPS. The company’s revenue was down 7.0% compared to the same quarter last year. Analysts anticipate that DENTSPLY SIRONA Inc. will post 1.12 EPS for the current year.

XRAY has been the topic of a number of recent research reports. BidaskClub upgraded shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research note on Tuesday, September 15th. Zacks Investment Research raised shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating and set a $47.00 target price on the stock in a research note on Monday, August 17th. JPMorgan Chase & Co. raised their price target on shares of DENTSPLY SIRONA from $45.00 to $47.00 and gave the stock a “neutral” rating in a research note on Monday, October 5th. Barclays downgraded DENTSPLY SIRONA from an “equal weight” rating to an “underweight” rating and set a $40.00 price objective on the stock. in a report on Tuesday, November 17th. Finally, Guggenheim raised DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a report on Thursday, October 22nd. One analyst has rated the stock with a sell rating, nine have issued a hold rating and eight have issued a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $49.53.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental products and technologies, and other consumable dental products and equipment primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Featured Story: NASDAQ

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.